Industry Research Reports and Market Analysis at MindBranch.com

Australia Cardiovascular Devices Investment Opportunities, Analysis and Forecasts to 2015

Published By: Global Markets Direct
May 2009
R3480-13929
Online Download   $2,500.00
Global Site License   $7,500.00
Description

Australia Cardiovascular Devices Investment Opportunities, Analysis and Forecasts to 2015

Summary

This report is an essential source for in-depth information and data relating to Australia cardiovascular devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and the latest news, financial deals and pipeline products information of each of the key sub-segments of the cardiovascular devices market in Australia

Scope
  • The report provides cardiovascular devices market information broken down into detailed categories and segments in Australia.
  • Total revenues, products sold, end users, and average pricing.
  • Market shares of all the key competitors.
  • Key pipeline products that are set to shape the market, broken down by sector.
  • Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
  • Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
  • Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
  • Key mergers and acquisitions, partnerships, private equity investments and IPOs.
  • Customer, hospitals and physicians data.
Reasons to buy
  • Gain a strong understanding of the cardiovascular devices market in Australia.
  • Evaluate and compare the attractiveness of the market in the country.
  • Identify growth segments and opportunities in each industry sector within the country.
  • Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
  • Analyze the competitiveness of the market in the country and identify hotspots.
  • Develop strategies based on the latest product, brand, expansion and research and development news in the country.
  • Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
  • Identify and analyze the strengths and weaknesses of the industry incumbents in the country.
Table of Contents
1 Table of Contents
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
3 Definitions of Markets Covered in This Report
3.1 Cardiovascular Devices
3.2 Cardiac Rhythm Management
3.2.1 Pacemakers
3.2.2 Implantable Cardioverter Defibrillator (ICD)
3.2.3 Cardiovascular Pacing and ICD Leads
3.2.4 Cardiac Resynchronization Therapy
3.3 Cardiovascular monitoring and diagnostic devices
3.3.1 ECG Monitoring Equipment
3.3.2 ECG Stress Testing Systems
3.3.3 Holter Monitoring Systems
3.3.4 Event Monitoring Systems
3.4 Cardiovascular prosthetic device
3.4.1 Prosthetic heart valves
3.4.2 Cardiac Valve Repair
3.4.3 Cardiac assist devices (Ventricular Assist Device (VAD))
3.5 Cardiovascular Surgery
3.5.1 Beating Heart Systems
3.5.2 Perfusion Systems
3.5.3 Cardiac Ablation Devices
3.5.4 Cardiopulmonary Bypass Equipment
3.5.5 Perfusion Disposables
3.6 Electrophysiology
3.6.1 Electrophysiology diagnostic catheter
3.6.2 Electrophysiology ablation catheter
3.6.3 Electrophysiology lab systems
3.7 Interventional cardiology
3.7.1 Coronary Stents
3.7.2 Cardiac Catheters
3.7.3 Percutaneous Transluminal Coronary Balloon (PTCA) Balloon Catheters
3.7.4 Coronary Guidewire
3.7.5 Arteriotomy Closure Devices
3.8 Peripheral vascular devices
3.8.1 Peripheral Vascular Stents
3.8.2 Inferior Vena Cava Filter
3.8.3 PTA Balloon
3.8.4 Aortic Stent Graft
3.8.5 Embolic Protection Device
3.8.6 Synthetic Surgical Grafts
3.8.7 Peripheral Guidewire
4 Healthcare Sector Review
4.1 Healthcare Expenditure
4.2 Healthcare Infrastructure
4.3 Healthcare Policy
5 Regulation System
5.1 Medical Equipment Approval Process
5.1.1 Market Authorization Holder (MAH)
5.1.2 Classification and Pre-Market Approval of Medical Devices
5.1.3 Third Party Certification for Controlled Medical Devices
5.1.4 PMDA Approval for Highly Controlled Medical Devices
5.1.5 Registration Time
5.1.6 Registration Fee
5.1.7 Post Marketing Surveillance
5.1.8 Labeling and Packaging
6 Pricing and Reimbursement
6.1 Market Pricing
6.2 Reimbursement Policies
6.3 Reimbursement Classes
6.3.1 Class A
6.3.2 Class B
6.3.3 Class C
6.3.4 Class F
6.4 Request for Reimbursement
6.5 Reduction in Reimbursement for Medical Devices and Drugs
7 Distribution Structure
8 Cardiovascular Devices In Japan
8.1 Cardiovascular Devices, Cross Country Comparison, Revenue ($ mn), 2000-2015
8.2 Cardiovascular Devices, Japan, Overall Revenue ($ mn), 2000-2015
8.3 Cardiovascular Devices, Japan, Category Volume (Units), 2000-2015
8.4 Cardiovascular Devices, Japan, Company Share (2007-2008)
9 Cardiac Rhythm Management In Japan
9.1 Cardiac Rhythm Management Overall Revenue (2000-2015)
9.1.1 Cardiac Resynchronisation Therapy Revenue (2000-2015)
9.1.2 Implantable Cardioverter Defibrillator Revenue (2000-2015)
9.1.3 Pacemaker Revenue (2000-2015)
9.2 Cardiac Rhythm Management Overall Volume (2000-2015)
9.2.1 Cardiac Resynchronisation Therapy Volume (2000-2015)
9.2.2 Implantable Cardioverter Defibrillator Volume (2000-2015)
9.2.3 Pacemaker Volume (2000-2015)
9.3 Cardiac Rhythm Management Average Price (2000-2015)
9.4 Cardiac Rhythm Management Distribution Share (2007-2008)
9.5 Cardiac Rhythm Management, Japan, Company Share (2007-2008)
10 Cardiovascular Monitoring and Diagnostic Devices In Japan
10.1 Cardiovascular Monitoring and Diagnostic Devices Overall Revenue (2000-2015)
10.2 Cardiovascular Monitoring and Diagnostic Devices Overall Volume (2000-2015)
10.3 Cardiovascular Monitoring and Diagnostic Devices Average Price (2000-2015)
10.4 Cardiovascular Monitoring and Diagnostic Devices Distribution Share (2007-2008)
10.5 Cardiovascular Monitoring and Diagnostic Devices, Japan, Company Share (2007-2008)
11 Cardiovascular Prosthetic Devices In Japan
11.1 Cardiovascular Prosthetic Devices Overall Revenue (2000-2015)
11.1.1 Prosthetic Heart Valve Revenue (2000-2015)
11.2 Cardiovascular Prosthetic Devices Overall Volume (2000-2015)
11.2.1 Prosthetic Heart Valve Volume (2000-2015)
11.3 Cardiovascular Prosthetic Devices Average Price (2000-2015)
11.4 Cardiovascular Prosthetic Devices Distribution Share (2007-2008)
11.5 Cardiovascular Prosthetic Devices, Japan, Company Share (2007-2008)
12 Cardiovascular Surgery In Japan
12.1 Cardiovascular Surgery Overall Revenue (2000-2015)
12.1.1 Perfusion Disposables Revenue (2000-2015)
12.2 Cardiovascular Surgery Overall Volume (2000-2015)
12.2.1 Perfusion Disposables Volume (2000-2015)
12.3 Cardiovascular Surgery Average Price (2000-2015)
12.4 Cardiovascular Surgery Distribution Share (2007-2008)
12.5 Cardiovascular Surgery, Japan, Company Share (2007-2008)
13 Electrophysiology In Japan
13.1 Electrophysiology Overall Revenue (2000-2015)
13.2 Electrophysiology Overall Volume (2000-2015)
13.3 Electrophysiology Average Price (2000-2015)
13.4 Electrophysiology, Japan, Company Share (2007-2008)
14 Interventional Cardiology In Japan
14.1 Interventional Cardiology Overall Revenue (2000-2015)
14.1.1 Cardiac Catheter Revenue (2000-2015)
14.1.2 Coronary Stent Revenue (2000-2015)
14.1.3 PTCA Balloon Revenue (2000-2015)
14.2 Interventional Cardiology Overall Volume (2000-2015)
14.2.1 Cardiac Catheter Volume (2000-2015)
14.2.2 Coronary Stent Volume (2000-2015)
14.2.3 PTCA Balloon Volume (2000-2015)
14.3 Interventional Cardiology Average Price (2000-2015)
14.4 Interventional Cardiology Distribution Share (2007-2008)
14.5 Interventional Cardiology, Japan, Company Share (2007-2008)
15 Peripheral Vascular Devices In Japan
15.1 Peripheral Vascular Devices Overall Revenue (2000-2015)
15.2 Peripheral Vascular Devices Overall Volume (2000-2015)
15.3 Peripheral Vascular Devices Average Price (2000-2015)
15.4 Peripheral Vascular Devices Distribution Share (2007-2008)
15.5 Peripheral Vascular Devices, Japan, Company Share (2007-2008)
16 Overview of Key Companies in Japan Cardiovascular Devices Market
16.1 Terumo Corporation
16.1.1 Company Overview
16.1.2 Value Chain Analysis
16.1.3 Terumo Corporation Pipeline Products
16.2 St. Jude Medical, Inc.
16.2.1 Company Overview
16.2.2 Value Chain Analysis
16.2.3 St. Jude Medical Inc. Pipeline Products
16.3 Sorin S.p.A.
16.3.1 Company Overview
16.3.2 Value Chain Analysis
16.3.3 Sorin Group Pipeline Products
16.4 Philips Healthcare
16.4.1 Company Overview
16.4.2 Value Chain Analysis
16.4.3 Philips Medical Systems Pipeline Products
16.5 OSI Systems, Inc.
16.5.1 Company Overview
16.5.2 Value Chain Analysis
16.6 Nihon Kohden Corporation
16.6.1 Company Overview
16.6.2 Value Chain Analysis
16.7 Medtronic, Inc.
16.7.1 Company Overview
16.7.2 Value Chain Analysis
16.7.3 Medtronic, Inc. Pipeline Products
16.8 MAQUET GmbH & Co. KG
16.8.1 Company Overview
16.9 JMS CO., LTD.
16.9.1 Company Overview
16.10 GE Healthcare
16.10.1 Company Overview
16.11 Fukuda Denshi Co., Ltd.
16.11.1 Company Overview
16.12 ev3 Inc.
16.12.1 Company Overview
16.12.2 Value Chain Analysis
16.12.3 ev3 Inc. Pipeline Products
16.13 Edwards Lifesciences Corporation
16.13.1 Company Overview
16.13.2 Value Chain Analysis
16.13.3 Edwards Lifesciences Corporation Pipeline Products
16.14 Datascope Corporation
16.14.1 Company Overview
16.14.2 Value Chain Analysis
16.15 Cordis Corporation
16.15.1 Company Overview
16.15.2 Cordis Corporation Pipeline Products
16.16 Cardiac Science Corporation
16.16.1 Company Overview
16.16.2 Value Chain Analysis
16.17 C.R. Bard, Inc.
16.17.1 Company Overview
16.17.2 Value Chain Analysis
16.17.3 C.R. Bard, Inc. Pipeline Products
16.18 Boston Scientific Corporation
16.18.1 Company Overview
16.18.2 Value Chain Analysis
16.18.3 Boston Scientific Corporation Pipeline Products
16.19 BIOTRONIK GmbH & Co. KG
16.19.1 Company Overview
16.19.2 BIOTRONIK GmbH & Co. KG Pipeline Products
16.20 Biosense Webster, Inc.
16.20.1 Company Overview
16.21 AtriCure, Inc.
16.21.1 Company Overview
16.21.2 AtriCure, Inc. Pipeline Products
16.22 Arrow International, Inc.
16.22.1 Company Overview
16.22.2 Value Chain Analysis
16.22.3 Arrow International, Inc. Pipeline Products
16.23 ABIOMED, Inc.
16.23.1 Company Overview
16.23.2 Value Chain Analysis
16.23.3 ABIOMED, Inc. Pipeline Products
16.24 Abbott Laboratories
16.24.1 Company Overview
16.24.2 Value Chain Analysis
16.25 ASAHI INTECC CO., LTD.
16.25.1 Company Overview
16.26 USCI Japan, Ltd.
16.26.1 Company Overview
16.27 Goodman Co., Ltd.
16.27.1 Company Overview
16.27.2 Goodman Co., Ltd. Pipeline Products
16.28 Medikit Co., Ltd.
16.28.1 Company Overview
16.29 Sun Medical Technology Research Corp.
16.29.1 Company Overview
16.30 Japan Lifeline Co., Ltd.
16.30.1 Company Overview
16.31 DVx, Inc.
16.31.1 Company Overview
17 Recent Developments
17.1 Product Approvals
17.1.1 Apr 16, 2009: ATS Medical Receives Japanese Approval For ATS Open Pivot AP360 Mechanical Heart Valve
17.1.2 Apr 14, 2009: Medtronic Announces Japanese Approval For Talent Thoracic Stent Graft
17.1.3 Mar 30, 2009: Medtronic Receives Regulatory Approval For Endeavor Drug-Eluting Coronary Stent In Japan
17.1.4 Jan 28, 2009: TAXUS Liberte Drug-Eluting Stent System Of Boston Scientific Gains Japanese Approval
17.1.5 Jan 14, 2009: St. Jude Medical Receives Japanese Approval For Atlas II Implantable Cardioverter Defibrillator
17.1.6 Jan 07, 2009: AGA Medical’s AMPLATZER Duct Occluder Receives Japanese Approval
18 Appendix
18.1 Global Markets Direct Research Methodology
18.2 Coverage
18.3 Secondary Research
18.4 Primary Research
18.5 Models
18.6 Forecasts
18.7 Expert Panel Validation
18.8 Currency Conversion
18.9 Contact Us
18.10 Disclaimer
1.1 List of Tables
Table 1: Healthcare Infrastructure in Australia, 2005
Table 2: Healthcare Personnel in Australia, 2005
Table 3: Hospital Wards by Specialty in Australia, 2003-2007
Table 4: Doctors by Specialty in Australia, 2003-2007
Table 5: Conformity Assessment of Medical Devices based Device Class, in Australia, 2007
Table 6: Fee for Registered Device in Australia, 2007
Table 7: Fee for Device Clinical Trial in Australia, 2007
Table 8: Evaluation Fee for High and Low Level Registration of Medical Device in Australia, 2007
Table 9: Evaluation Fee for Variation Registration of Medical Device in Australia, 2007
Table 10: Fee for Registration of Listed Devices in Australia, 2007
Table 11: Fee for Registration of Listed Devices for Export Only in Australia, 2007
Table 12: Fee for Registration of Included Devices in Australia, 2007
Table 13: Fee for Initial Conformity Assessment of Medical Device in Australia, 2007
Table 14: Fee for Medical Device Changes Conformity Assessment in Australia, 2007
Table 15: Fee for Medical Device Conformity Assessment Surveillance Audit in Australia, 2007
Table 16: Fee for Medical Device Conformity Assessment Review Certificate in Australia, 2007
Table 17: Fee for Initial Conformity Assessment of Medical Device Components in Australia, 2007
Table 18: Fee for Conformity Assessment of Changes in Medical Device Components in Australia, 2007
Table 19: Fee for Abridged Conformity Assessment of Medical Device Components in Australia, 2007
Table 20: Fee for Inclusion of Medical Device in the Register in Australia, 2007
Table 21: Fee for ARTG Inclusion for Medical Device in Australia, 2007
Table 22: Cardiovascular Devices Cross Country Comparison, Revenue ($ mn), 2000-2015
Table 23: Cardiovascular Devices, Australia, Overall Revenue ($ mn), 2000-2015
Table 24: Cardiovascular Devices, Australia, Cross-Category Analysis, 2000-2015
Table 25: Cardiovascular Devices, Australia, Overall Revenue ($ mn), Historic, 2000-2008
Table 26: Cardiovascular Devices, Australia, Overall Revenue ($ mn), Forecast, 2008-2015
Table 27: Cardiovascular Devices, Australia, Category Volume (Units), 2000-2015
Table 28: Cardiovascular Devices, Australia, Category Volume (Units), Historic, 2000-2008
Table 29: Cardiovascular Devices, Australia, Category Volume (Units), Forecast, 2008-2015
Table 30: Cardiovascular Devices, Australia, Company Share by Revenue ($ mn), 2007-2008
Table 31: Cardiac Rhythm Management, Australia, Revenue ($ mn) by Segment, Historic, 2000-2008
Table 32: Cardiac Rhythm Management, Australia, Revenue ($ mn) by Segment, Forecast, 2008-2015
Table 33: Cardiac Resynchronisation Therapy, Australia, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
Table 34: Cardiac Resynchronisation Therapy, Australia, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
Table 35: Implantable Cardioverter Defibrillator, Australia, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
Table 36: Implantable Cardioverter Defibrillator, Australia, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
Table 37: Pacemaker, Australia, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
Table 38: Pacemaker, Australia, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
Table 39: Cardiac Rhythm Management, Australia, Volume (Units) by Segment, Historic, 2000-2008
Table 40: Cardiac Rhythm Management, Australia, Volume (Units) by Segment, Forecast, 2008-2015
Table 41: Cardiac Resynchronisation Therapy, Australia, Volume (Units) by Sub-Segment, Historic, 2000-2008
Table 42: Cardiac Resynchronisation Therapy, Australia, Volume (Units) by Sub-Segment, Forecast, 2008-2015
Table 43: Implantable Cardioverter Defibrillator, Australia, Volume (Units) by Sub-Segment, Historic, 2000-2008
Table 44: Implantable Cardioverter Defibrillator, Australia, Volume (Units) by Sub-Segment, Forecast, 2008-2015
Table 45: Pacemaker, Australia, Volume (Units) by Sub-Segment, Historic, 2000-2008
Table 46: Pacemaker, Australia, Volume (Units) by Sub-Segment, Forecast, 2008-2015
Table 47: Cardiac Rhythm Management, Australia, Average Price ($), Historic, 2000-2008
Table 48: Cardiac Rhythm Management, Australia, Average Price ($), Forecast, 2008-2015
Table 49: Cardiac Rhythm Management, Australia, Distribution Share by Revenue ($mn), 2007-2008
Table 50: Cardiac Rhythm Management, Australia, Company Share by Revenue ($ mn), 2007-2008
Table 51: Cardiovascular Monitoring and Diagnostic Devices, Australia, Revenue ($ mn) by Segment, Historic, 2000-2008
Table 52: Cardiovascular Monitoring and Diagnostic Devices, Australia, Revenue ($ mn) by Segment, Forecast, 2008-2015
Table 53: Cardiovascular Monitoring and Diagnostic Devices, Australia, Volume (Units) by Segment, Historic, 2000-2008
Table 54: Cardiovascular Monitoring and Diagnostic Devices, Australia, Volume (Units) by Segment, Forecast, 2008-2015
Table 55: Cardiovascular Monitoring and Diagnostic Devices, Australia, Average Price ($), Historic, 2000-2008
Table 56: Cardiovascular Monitoring and Diagnostic Devices, Australia, Average Price ($), Forecast, 2008-2015
Table 57: Cardiovascular Monitoring and Diagnostic Devices, Australia, Distribution Share by Revenue ($mn), 2007-2008
Table 58: Cardiovascular Monitoring and Diagnostic Devices, Australia, Company Share by Revenue ($ mn), 2007-2008
Table 59: Cardiovascular Prosthetic Devices, Australia, Revenue ($ mn) by Segment, Historic, 2000-2008
Table 60: Cardiovascular Prosthetic Devices, Australia, Revenue ($ mn) by Segment, Forecast, 2008-2015
Table 61: Cardiac Assist Devices, Australia, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
Table 62: Cardiac Assist Devices, Australia, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
Table 63: Prosthetic Heart Valve, Australia, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
Table 64: Prosthetic Heart Valve, Australia, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
Table 65: Cardiovascular Prosthetic Devices, Australia, Volume (Units) by Segment, Historic, 2000-2008
Table 66: Cardiovascular Prosthetic Devices, Australia, Volume (Units) by Segment, Forecast, 2008-2015
Table 67: Cardiac Assist Devices, Australia, Volume (Units) by Sub-Segment, Historic, 2000-2008
Table 68: Cardiac Assist Devices, Australia, Volume (Units) by Sub-Segment, Forecast, 2008-2015
Table 69: Prosthetic Heart Valve, Australia, Volume (Units) by Sub-Segment, Historic, 2000-2008
Table 70: Prosthetic Heart Valve, Australia, Volume (Units) by Sub-Segment, Forecast, 2008-2015
Table 71: Cardiovascular Prosthetic Devices, Australia, Average Price ($), Historic, 2000-2008
Table 72: Cardiovascular Prosthetic Devices, Australia, Average Price ($), Forecast, 2008-2015
Table 73: Cardiovascular Prosthetic Devices, Australia, Distribution Share by Revenue ($mn), 2007-2008
Table 74: Cardiovascular Prosthetic Devices, Australia, Company Share by Revenue ($ mn), 2007-2008
Table 75: Cardiovascular Surgery, Australia, Revenue ($ mn) by Segment, Historic, 2000-2008
Table 76: Cardiovascular Surgery, Australia, Revenue ($ mn) by Segment, Forecast, 2008-2015
Table 77: Perfusion Disposables, Australia, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
Table 78: Perfusion Disposables, Australia, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
Table 79: Cardiovascular Surgery, Australia, Volume (Units) by Segment, Historic, 2000-2008
Table 80: Cardiovascular Surgery, Australia, Volume (Units) by Segment, Forecast, 2008-2015
Table 81: Perfusion Disposables, Australia, Volume (Units) by Sub-Segment, Historic, 2000-2008
Table 82: Perfusion Disposables, Australia, Volume (Units) by Sub-Segment, Forecast, 2008-2015
Table 83: Cardiovascular Surgery, Australia, Average Price ($), Historic, 2000-2008
Table 84: Cardiovascular Surgery, Australia, Average Price ($), Forecast, 2008-2015
Table 85: Cardiovascular Surgery, Australia, Distribution Share by Revenue ($mn), 2007-2008
Table 86: Cardiovascular Surgery, Australia, Company Share by Revenue ($ mn), 2007-2008
Table 87: Electrophysiology, Australia, Revenue ($ mn) by Segment, Historic, 2000-2008
Table 88: Electrophysiology, Australia, Revenue ($ mn) by Segment, Forecast, 2008-2015
Table 89: Electrophysiology, Australia, Volume (Units) by Segment, Historic, 2000-2008
Table 90: Electrophysiology, Australia, Volume (Units) by Segment, Forecast, 2008-2015
Table 91: Electrophysiology, Australia, Average Price ($), Historic, 2000-2008
Table 92: Electrophysiology, Australia, Average Price ($), Forecast, 2008-2015
Table 93: Electrophysiology, Australia, Distribution Share by Revenue ($mn), 2007-2008
Table 94: Electrophysiology, Australia, Company Share by Revenue ($ mn), 2007-2008
Table 95: Interventional Cardiology, Australia, Revenue ($ mn) by Segment, Historic, 2000-2008
Table 96: Interventional Cardiology, Australia, Revenue ($ mn) by Segment, Forecast, 2008-2015
Table 97: Cardiac Catheter, Australia, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
Table 98: Cardiac Catheter, Australia, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
Table 99: Coronary Stent, Australia, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
Table 100: Coronary Stent, Australia, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
Table 101: PTCA Balloon, Australia, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
Table 102: PTCA Balloon, Australia, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
Table 103: Interventional Cardiology, Australia, Volume (Units) by Segment, Historic, 2000-2008
Table 104: Interventional Cardiology, Australia, Volume (Units) by Segment, Forecast, 2008-2015
Table 105: Cardiac Catheter, Australia, Volume (Units) by Sub-Segment, Historic, 2000-2008
Table 106: Cardiac Catheter, Australia, Volume (Units) by Sub-Segment, Forecast, 2008-2015
Table 107: Coronary Stent, Australia, Volume (Units) by Sub-Segment, Historic, 2000-2008
Table 108: Coronary Stent, Australia, Volume (Units) by Sub-Segment, Forecast, 2008-2015
Table 109: PTCA Balloon, Australia, Volume (Units) by Sub-Segment, Historic, 2000-2008
Table 110: PTCA Balloon, Australia, Volume (Units) by Sub-Segment, Forecast, 2008-2015
Table 111: Interventional Cardiology, Australia, Average Price ($), Historic, 2000-2008
Table 112: Interventional Cardiology, Australia, Average Price ($), Forecast, 2008-2015
Table 113: Interventional Cardiology, Australia, Distribution Share by Revenue ($mn), 2007-2008
Table 114: Interventional Cardiology, Australia, Company Share by Revenue ($ mn), 2007-2008
Table 115: Peripheral Vascular Devices, Australia, Revenue ($ mn) by Segment, Historic, 2000-2008
Table 116: Peripheral Vascular Devices, Australia, Revenue ($ mn) by Segment, Forecast, 2008-2015
Table 117: Peripheral Vascular Devices, Australia, Volume (Units) by Segment, Historic, 2000-2008
Table 118: Peripheral Vascular Devices, Australia, Volume (Units) by Segment, Forecast, 2008-2015
Table 119: Peripheral Vascular Devices, Australia, Average Price ($), Historic, 2000-2008
Table 120: Peripheral Vascular Devices, Australia, Average Price ($), Forecast, 2008-2015
Table 121: Peripheral Vascular Devices, Australia, Distribution Share by Revenue ($mn), 2007-2008
Table 122: Peripheral Vascular Devices, Australia, Company Share by Revenue ($ mn), 2007-2008
Table 123: Terumo Corporation Pipeline Products by Equipment Type
Table 124: Terumo Corporation Pipeline Products By Development Stage
Table 125: Terumo Corporation Pipeline Products By Therapy Area
Table 126: Terumo Corporation Pipeline Products By Clinical Trials
Table 127: Terumo Corporation Pipeline Products By News Summary
Table 128: St. Jude Medical Inc. Pipeline Products by Equipment Type
Table 129: St. Jude Medical Inc. Pipeline Products By Development Stage
Table 130: St. Jude Medical Inc. Pipeline Products By Therapy Area
Table 131: St. Jude Medical Inc. Pipeline Products By Clinical Trials
Table 132: St. Jude Medical Inc. Pipeline Products By News Summary
Table 133: Sorin Group Pipeline Products by Equipment Type
Table 134: Sorin Group Pipeline Products By Development Stage
Table 135: Sorin Group Pipeline Products By Therapy Area
Table 136: Sorin Group Pipeline Products By Clinical Trials
Table 137: Sorin Group Pipeline Products By News Summary
Table 138: Philips Medical Systems Pipeline Products by Equipment Type
Table 139: Philips Medical Systems Pipeline Products By Development Stage
Table 140: Philips Medical Systems Pipeline Products By Therapy Area
Table 141: Philips Medical Systems Pipeline Products By Clinical Trials
Table 142: Philips Medical Systems Pipeline Products By News Summary
Table 143: Medtronic, Inc. Pipeline Products by Equipment Type
Table 144: Medtronic, Inc. Pipeline Products By Development Stage
Table 145: Medtronic, Inc. Pipeline Products By Therapy Area
Table 146: Medtronic, Inc. Pipeline Products By Clinical Trials
Table 147: Medtronic, Inc. Pipeline Products By News Summary
Table 148: ev3 Inc. Pipeline Products by Equipment Type
Table 149: ev3 Inc. Pipeline Products By Development Stage
Table 150: ev3 Inc. Pipeline Products By Therapy Area
Table 151: ev3 Inc. Pipeline Products By Clinical Trials
Table 152: ev3 Inc. Pipeline Products By News Summary
Table 153: Edwards Lifesciences Corporation Pipeline Products by Equipment Type
Table 154: Edwards Lifesciences Corporation Pipeline Products By Development Stage
Table 155: Edwards Lifesciences Corporation Pipeline Products By Therapy Area
Table 156: Edwards Lifesciences Corporation Pipeline Products By Clinical Trials
Table 157: Edwards Lifesciences Corporation Pipeline Products By News Summary
Table 158: Cordis Corporation Pipeline Products by Equipment Type
Table 159: Cordis Corporation Pipeline Products By Development Stage
Table 160: Cordis Corporation Pipeline Products By Therapy Area
Table 161: Cordis Corporation Pipeline Products By Clinical Trials
Table 162: Cordis Corporation Pipeline Products By News Summary
Table 163: C.R. Bard, Inc. Pipeline Products by Equipment Type
Table 164: C.R. Bard, Inc. Pipeline Products By Development Stage
Table 165: C.R. Bard, Inc. Pipeline Products By Therapy Area
Table 166: C.R. Bard, Inc. Pipeline Products By Clinical Trials
Table 167: Boston Scientific Corporation Pipeline Products by Equipment Type
Table 168: Boston Scientific Corporation Pipeline Products By Development Stage
Table 169: Boston Scientific Corporation Pipeline Products By Therapy Area
Table 170: Boston Scientific Corporation Pipeline Products By Clinical Trials
Table 171: Boston Scientific Corporation Pipeline Products By News Summary
Table 172: BIOTRONIK GmbH & Co. KG Pipeline Products by Equipment Type
Table 173: BIOTRONIK GmbH & Co. KG Pipeline Products By Development Stage
Table 174: BIOTRONIK GmbH & Co. KG Pipeline Products By Therapy Area
Table 175: BIOTRONIK GmbH & Co. KG Pipeline Products By Clinical Trials
Table 176: BIOTRONIK GmbH & Co. KG Pipeline Products By News Summary
Table 177: Arrow International, Inc. Pipeline Products by Equipment Type
Table 178: Arrow International, Inc. Pipeline Products By Development Stage
Table 179: Arrow International, Inc. Pipeline Products By Therapy Area
Table 180: Arrow International, Inc. Pipeline Products By Clinical Trials
Table 181: ABIOMED, Inc. Pipeline Products by Equipment Type
Table 182: ABIOMED, Inc. Pipeline Products By Development Stage
Table 183: ABIOMED, Inc. Pipeline Products By Therapy Area
Table 184: ABIOMED, Inc. Pipeline Products By Clinical Trials
Table 185: ABIOMED, Inc. Pipeline Products By News Summary
Table 186: AtCor Medical Holdings Limited Pipeline Products by Equipment Type
Table 187: AtCor Medical Holdings Limited Pipeline Products By Development Stage
Table 188: AtCor Medical Holdings Limited Pipeline Products By Therapy Area
Table 189: AtCor Medical Holdings Limited Pipeline Products By Clinical Trials
Table 190: Sunshine Heart, Inc. Pipeline Products by Equipment Type
Table 191: Sunshine Heart, Inc. Pipeline Products By Development Stage
Table 192: Sunshine Heart, Inc. Pipeline Products By Clinical Trials
Table 193: Sunshine Heart, Inc. Pipeline Products By News Summary
Table 194: Ventracor Limited Pipeline Products by Equipment Type
Table 195: Ventracor Limited Pipeline Products By Development Stage
Table 196: Ventracor Limited Pipeline Products By Therapy Area
Table 197: Ventracor Limited Pipeline Products By Clinical Trials
Table 198: Ventracor Limited Pipeline Products By News Summary
Table 199: CathRx Ltd Pipeline Products by Equipment Type
Table 200: CathRx Ltd Pipeline Products By Development Stage
Table 201: CathRx Ltd Pipeline Products By Therapy Area
Table 202: CathRx Ltd Pipeline Products By News Summary
Table 203: BioQ Devices Pty Ltd Pipeline Products by Equipment Type
Table 204: BioQ Devices Pty Ltd Pipeline Products By Development Stage
Table 205: BioQ Devices Pty Ltd Pipeline Products By Therapy Area
Table 206: Thoratec To Acquire HeartWare International
Table 207: USD to Local Currency, Average Exchange Rate 2008
1.2 List of Figures
Figure 1: Total Healthcare Expenditure in Australia, 2000 - 2005
Figure 2: Healthcare Financing Framework in Australia, 2007
Figure 3: Healthcare System in Australia, 2007
Figure 4: Classification of Medical Devices in Australia, 2007
Figure 5: Classification of Noninvasive Devices in Australia, 2007
Figure 6: Classification of Invasive Devices in Australia, 2007
Figure 7: Classification of Invasive Devices in Australia, 2007
Figure 8: Classification of Active Devices in Australia, 2007
Figure 9: Classification of Special Medical Devices in Australia, 2007
Figure 10: Conformity Assessment Procedure for Medical Devices in Australia, 2007
Figure 11: Cardiovascular Devices Cross Country Comparison, Revenue ($ mn), 2000-2015
Figure 12: Cardiovascular Devices, Australia, Overall Revenue ($ mn), 2000-2015
Figure 13: Cardio
Order Form
       * Please reference product number R3480-13929 when ordering or inquiring.
PUBLICATION:   Australia Cardiovascular Devices Investment Opportunities, Analysis and Forecasts to 2015
QTY. FORMAT PRICE TOTAL
  Online Download$2,500.00   
  Global Site License$7,500.00   
  SUBTOTAL   
SHIPPING CHARGES
 (U.S. $25, Canada $35, Int'l $65) 		 
TOTAL  

CONTACT INFORMATION
PAYMENT INFORMATION
Name ____________________________________________ MasterCard VISA AmEx Discover

__________________________________
Account number                 Exp. date

__________________________________
Signature

__________________________________
Email

Please invoice
      (shipment on receipt of payment)
Payment enclosed
*CHECKS / WIRE TRANSFERS:
Checks must be paid in U.S. funds.
Please call for details.
Company ____________________________________________
Job Title ____________________________________________
Address ____________________________________________
City ____________________________________________
Company ____________________________________________
State ______________________________   Zip__________
Country ____________________________________________
Phone ____________________________________________
MindBranch, Inc.,     131 Ashland St., Suite 200 North Adams, MA  01247       tel: 800-774-4410     fax: +1-413-664-9791     www.mindbranch.com